Pharming vaccines for hepatitis and cytomegalovirus: Towards the development of multivalent and subunit vaccines for oral delivery of antigens

Phytochemistry Reviews

Volumn 1, Issue 1, 2002, Pages 55-66

  Alli, Zaman ^a   Sardana, Ravinder K ^a   Pierre, Béatrice ^a,d   Andonov, Anton ^b   Robert, Laurian S ^c   Schernthaner, Johann P ^c   Porter, Suzanne L ^d   Dudani, Anil K ^a,d   Ganz, Peter R ^a,d   Tackaberry, Eilleen S ^a,d   Altosaar, Illimar ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c AGRICULTURE AND AGRI FOOD CANADA   (Canada)

^d HEALTH CANADA   (Canada)

Author keywords

Double 35S promoter; Glutelin1 promoter; Human cytomegalovirus glycoprotein B; Multivalent vaccines; Oral antigens; Oral immunization; Recombinant protein expression; Subunit vaccines; Transgenic seeds; Truncated hepatitis B core particle

Indexed keywords

CYTOMEGALOVIRUS VACCINE; GLYCOPROTEIN B; HEPATITIS VACCINE; NUCLEOCAPSID PROTEIN;

ANTIGEN PRESENTATION; CELL TRANSFORMATION; DRUG MANUFACTURE; DRUG SYNTHESIS; GENE EXPRESSION; GENE SEQUENCE; HEPATITIS B VIRUS; HUMAN CYTOMEGALOVIRUS; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOSTIMULATION; NONHUMAN; PLANT BIOTECHNOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; VACCINE PRODUCTION; VIRUS GENE; VIRUS NUCLEOCAPSID; WESTERN BLOTTING;

CYTOMEGALOVIRUS; DAUCUS CAROTA; HEPATITIS B VIRUS; HUMAN HERPESVIRUS 5; NICOTIANA OBTUSIFOLIA; NICOTIANA TABACUM;

EID: 0041634710     PISSN: 15687767     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015832302721     Document Type: Review

References (58)

1. Adeli K & Altosaar I (1984) Compartmentalization of seed reserve proteins. Proposed discriminatory factors. FEBS Lett. 178: 193-198.
2. Alli Z (2001) Expression of Biologically Active Human Granulocyte Macrophage Colony Stimulating Factor in the Seeds of Transgenic Tobacco. MSc thesis, University of Ottawa, Ottawa.
3. Alli Z, Sardana RK, Andonov A, Robert LS, Schemthaner JP & Altosaar I (2000a) Biological assembly of truncated hepatitis core antigen in transgenic plants: towards oral delivery of lowcost vaccines. Seventh annual national conference and exhibition, Ottawa, Canada, 4-6 December, 31 pp. Ottawa Life Sciences Council, Ottawa, Canada.
4. Alli Z, Sardana RK, Dudani A, Tackaberry E, Ganz PR, Panahi M, Narayanan M & Altosaar I (2000b) Harvesting of human serum cytokines from endosperm expression systems: evaluation of stability of antecedent and E. coli derived cytokines in biological assays. Seventh annual national conference and exhibition, Ottawa, Canada, 4-6 December, 25 pp. Ottawa Life Sciences Council, Ottawa, Canada.
5. Alli Z, Sardana RK, Andonov A, Robert LS, Schernthaner JP & Altosaar I (2001a) Plant codon-optimised hepatitisB core particle gene increases assembly of viral particles in transgenic plants: a technological advancement towards increased antibody titre from oral vaccines. Eighth annual national conference and exhibition, Ottawa, Canada, 5-7 November, 27 pp. Ottawa Life Sciences Council, Ottawa, Canada.
6. Alli Z, Sardana RK, Andonov A, Robert LS, Schernthaner JP & Altosaar I (2001b) B-Glucuronidase protein expressed in three different bioreactor lines of transgenic carrot: towards augmented, therapeutic peptide yields from edible plant tissues. Eighth annual national conference and exhibition, Ottawa, Canada, 5-7 November, 25 pp. Ottawa Life Sciences Council, Ottawa, Canada.
7. Arakawa T, Chong DK & Langridge WHR (1998a) Efficacy of a food plant-based oral cholera toxin B subunit vaccine. Nature Biotechnol. 16: 292-297 (Published erratum appears in Nature Biotechnol. 16: 478).
8. Arakawa T, Yu J, Daniel KXC, Hough J, Engen PC & Langridge WHR (1998b) A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes. Nature Biotechnol. 16: 934-938.
9. Brennan FR, Bellaby T, Helliwell SM, Jones TD, Kamstrup S, Dalsgaard K, Flock JI & Hamilton WD (1999) Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice. J. Virol. 73: 930-938.
10. Chargelegue D, Obregon P & Drake PM (2001) Transgenic plants for vaccine production: Expectations and limitations. Trends Plant Sci. 6: 495-496.
11. Cheng X, Sardana R & Altosaar I (1997) Recombinant proteins from plants: Production and isolation of clinically useful compounds. In: Cunningham C and Porter AJR (eds) Methods in Biotechnology (pp. 1-9). Humana, Totowa, New Jersey.
12. Cheng X, Sardana R, Kaplan H & Altosaar I (1998) Agrobacterium- transformed rice plants expressing synthetic CtyIA(b) and CiyIA(c) genes are highly toxic to yellow stem borer and striped stem borer. Proc. Natl. Acad. Sci. USA 95: 2767-2772.
13. Cramer CL, Boothe JG & Oishi KK (1999) Transgenic plants for therapeutic proteins: Linking upstream and downstream strategies. Curr. Top. Microbiol. Immunol. 240: 95-118.
14. Cramer CL, Weissenborn DL, Oishi KK, Grabau EA, Bennett S, Ponce E, Grabowski GA & Radin DN (1996) Bioproduction of human enzymes in transgenic tobacco. Ann. NY Acad. Sci. 792: 62-71.
15. Datla RSS, Hammerlindl JK, Panchuk B, Pelcher LE & Keller W (1992) Modified binary plant transformation vectors with the wild-type gene encoding NPTII. Gene 122: 383-384.
16. Datla RSS, Bekkaoui F, Hammerlindl JK, Pilate G, Dunstan DI & Crosby L (1993) Improved high-level constitutive foreign gene expression in plants using an AMV RNA4 untranslated leader sequence. Plant Sci. 94: 383-384.
17. deVos T & Dick TA (1991) A rapid method to determine the isotype and specificity of copro-antibodies in mice infected with Trichinella or fed cholera toxin. J. Immunol. Methods 141: 285-288.
18. Estrada A, McDermott MR, Underdown BJ & Snider DP (1995) Intestinal immunization of mice with antigen conjugated to anti-MHC class II antibodies. Vaccine 13: 901-907.
19. Fabijanski S, Chang S-C, Dukiandjiev S, Bahramian MB, Ferrara P & Altosaar I (1988) The nucleotide sequence of a cDNA clone for a major prolamin (Avenin) in oat (Avena sativa L. cultivar Hinoat) which reveals homology with oat globulin. Biochem. Physiol. Pflanz. 183: 143-152.
20. Ganz PR, Dudani AK, Tackaberry ES, Sardana R, Sauder C, Cheng X & Altosaar I (1995) Plants as factories for producing human blood proteins. Can. Soc. Transfus. Med. Bull. 7: 112-121.
21. Ganz PR, Dudani AK, Tackaberry ES, Sardana R, Sauder C, Cheng X & Altosaar I (1996) Expression of human blood proteins in transgenic plants: the cytokine GM-CSF as a model protein. In: Owen MRL and Pen J (eds) Transgenic Plants: A Production System for Pharmaceutical and Industrial Proteins (pp. 281-297). John Wiley and Sons Ltd, NY.
22. Haq TA, Mason HS, Clements JD & Arntzen CJ (1995) Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 268: 714-716.
23. Hardegger M & Sturm A (1998) Transformation and regeneration of carrot (Daucus carota L.). Mol. Breed. 4: 119-127.
24. Herbers K, Wilke I & Sonnewald UA (1995) Thermostable xylanase from Clostridium thermocellum expressed at high levels in the apoplast of transgenic tobacco has no detrimental effects and is easily purified. Bio/Technology 13: 63-66.
25. Ho M (ed.) (1991) Cytomegalovirus: Biology and Infection. 2nd edition. Plenum Medical Book Company, New York.
26. Horvath H, Huang J, Wong O, Kohl E, Okita T, Kannangara CG & von Wettstein D (2000) The production of recombinant proteins in transgenic barley grains. Proc. Natl. Acad. Sci. USA 97: 1914-1919.
27. Lauterslager TG, Florack DE, van der Wal TJ, Molthoff JW, Langeveld JP, Bosch D, Boersma WJ & Hilgers LA (2001) Oral immunisation of naive and primed animals with transgenic potato tubers expressing LT-B. Vaccine 19: 2749-2755.
28. Mason HS, Lam DMK & Arntzen CJ (1992) Expression of hepatitis B surface antigen in transgenic plants. Proc. Natl. Acad. Sci. USA 89: 11745-11749.
29. Mason HS, Ball JM, Shi JJ, Jiang X, Estes MK & Arntzen CJ (1996) Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc. Natl. Acad. Sci. USA 93: 5335-5340.
30. Mason HS, Haq TA, Clements JD & Arntzen CJ (1998) Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): Potatoes expressing a synthetic LT-B gene. Vaccine 16: 1336-1343.
31. McGarvey PB, Hammond J, Dienelt MM, Hooper DC, Fu ZF, Dietzschold B, Koprowski H & Michaels FH (1995) Expression of the rabies virus glycoprotein in transgenic tomatoes. Bio/Technology 13: 1484-1487.
32. Miller EA & Anderson MA (1999) Uncoating the mechanisms of vacuolar protein transport. Trends Plant Sci. 4: 46-48.
33. Modelska A, Dietzschold B, Sleysh N, Fu ZF, Steplewski K, Hooper DC, Koprowski H & Yusibov V (1998) Immunization against rabies with plant-derived antigen. Proc. Natl. Acad. Sci. USA 95:2481-2485.
34. Morton W (2001) Animal Models of Hepatitis. Instit. Labo. Anim. Res. J. (Nat. Res. Council, Washington D.C.) 42: 3.
35. Murray K & Shiau AL (1999) The core antigen of hepatitis B virus as a carrier for immunogenic peptides. Biol. Chem. 380: 277-283.
36. O'Hagen DT (ed.) (2000) Methods in Molecular Medicine: Vaccine Adjuvants. Humana Press Inc., Totowa, New Jersey.
37. Ogra PL, Faden H & Welliver R (2001) Vaccination strategies for mucosal immune responses. Clin. Microbiol. Rev. 14: 3430-3445.
38. Panahi M, Cheng X, Alli Z, Callaghan M, Sardana R, Muthukrishnan N & Altosaar I (2000) Expression of human insulin-like growth factor 1 (IGF1) and its precursor IGF1B in plants. Seventh annual national conference and exhibition, Ottawa, Canada, 4-6 December, 26 pp. Ottawa Life Sciences Council, Ottawa, Canada.
39. Pumpens P & Grens E (2001) HBV core particles as a carrier for B cell/T cell epitopes. Intervirology 44 (2-3): 98-114.
40. Richter L & Kipp PB (1999) Transgenic plants as edible vaccines. Curr. Top. Microbiol. Immunol. 240: 159-176.
41. Richter LJ, Thanavala Y, Arntzen CJ & Mason HS (2000) Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nature Biotechnol. 18: 1167-1171.
42. Robinson A (1995) Harvesting blood proteins from grain. Can. Med. Assoc. J. 153(4): 427-429.
43. Sandhu JS, Krasnyanski SF, Domier LL, Korban SS, Osadjan MD & Buetow DE (2000) Oral immunization of mice with transgenic tomato fruit expressing respiratory syncytial virus-F protein induces a systemic immune response. Transgen. Res. 9: 127-135.
44. Saleh AM, Nozzolillo C & Altosaar I (1988) Flavonoid variations in Avena species. Biochem. Sys. Ecol. 16: 597-599.
45. Sardana R, Ganz PR, Dudani A, Tackaberry ES, Cheng X & Altosaar I (1997) Synthesis of recombinant human cytokine GM-CSF in the seeds of transgenic tobacco plants. In: Cunningham C and Porter A (eds) Methods in Biotechnology (pp. 77-87). Humana Press Inc., Totowa, New Jersey.
46. Schouten A, Roosien J, van Engelen FA, de long GA, Borst-Vrenssen AW, Zilverentant JF, Bosch D, Stiekema WJ, Gommers FJ, Schots A & Bakker J (1996) The C-terminal KDEL sequence increases the expression level of a single-chain antibody designed to be targeted to both the cytosol and the secretory pathway in transgenic tobacco. Plant Mol. Biol. 30: 781-793.
47. Tackaberry E, Dudani AK, Prior F, Tocchi M, Sardana R, Altosaar I & Ganz PR (1999) Development of biopharmaceuticals in plant expression systems: cloning, expression and immunological reactivity of human cytomegalovirus glycoprotein B (UL55) in seeds of transgenic tobacco. Vaccine 17: 3020-3029.
48. Tackaberry ES, Wright KE, Dudani AK, Sardana R, Altosaar I & Ganz PR (2001) A seed-derived oral subunit vaccine for human cytomegalovirus. In: Erickson L (ed) Molecular Farming of Plants and Animals for Human and Veterinary Medicine. Kluwer Press (in press).
49. Tacket CO, Mason HS, Losonsky G, Estes MK, Levine MM & Arntzen CJ (2000) Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. J. Infect. Dis. 182: 302-305.
50. Tanchak MA, Schernthaner JP, Giband M & Altosaar I (1998) Tryptophanins: Isolation and molecular characterization of oat cDNA clones encoding proteins structurally related to puroindoline and wheat grain softness proteins. Plant Sci. 137: 173-184.
51. Thanavala Y, Yang YF, Lyons P, Mason HS & Amtzen C (1995) Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc. Natl. Acad. Sci. USA 92: 3358-3361.
52. Tsuda S, Yoshioka K, Tanaka T, Iwata A, Yoshikawa A, Watanabe Y & Okada Y (1998) Application of the human hepatitis B virus core antigen from transgenic tobacco plants for serological diagnosis. Vox Sang. 74: 148-155.
53. Walmsley AM & Arntzen CJ (2000) Plants for delivery of edible vaccines. Curr. Opin. Biotechnol. 11: 126-129.
54. Wright KE, Prior F, Sardana R, Altosaar I, Dudani AK, Ganz PR & Tackaberry ES (2001) Sorting of glycoprotein B from human cytomegalovirus to protein storage vesicles in seeds of transgenic tobacco. Transgen. Res. 10: 177-181.
55. Yiu SH, Collins FWC, Fulcher RG & Altosaar I (1984) Localization of glucosinolate in rapeseed protein bodies using N,2,6-trichloro-p-benzoquinone- imine. Can. J. Plant Sci. 64: 889-898.
56. Yiu SH, Poon NH, Fulcher RG & Altosaar I (1982) The microscopic structure and chemistry of rapeseed and its products. J. Food Microstruct. 1: 135-143.
57. Yusibov V, Modelska A, Steplewski K, Agadjanyan M, Weiner D, Hooper DC & Koprowski H (1997) Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1. Proceedings of the National Academy of Science (USA) 94(11): 5784-5788.
58. Zhang GG, Rodrigues L, Rovinski B & White KA (2002) Production of HIV-1 p24 protein in transgenic tobacco plants. Molecular Biotechnology 20(2): 131-136.